4ZYI
Discovery of NVP-CGM097 - a highly potent and selective MDM2 inhibitor undergoing phase 1 clinical trials in p53wt tumors: Hdm2 (MDM2) complexed with cpd2
Functional Information from GO Data
Functional Information from PDB Data
| site_id | AC1 |
| Number of Residues | 11 |
| Details | binding site for residue 4TH A 201 |
| Chain | Residue |
| A | GLN24 |
| A | TYR100 |
| A | HOH319 |
| A | LEU54 |
| A | PHE55 |
| A | MET62 |
| A | TYR67 |
| A | GLN72 |
| A | PHE86 |
| A | HIS96 |
| A | ARG97 |
| site_id | AC2 |
| Number of Residues | 7 |
| Details | binding site for residue CL A 202 |
| Chain | Residue |
| A | LYS64 |
| A | LYS64 |
| A | ASP80 |
| A | ASP80 |
| A | LEU81 |
| A | LEU81 |
| A | HOH325 |






